| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.6M | +92.1% |
| R&D Expense | $26.3M | +241.9% |
| SG&A Expense | $104.1M | +923.7% |
| Operating Income | -$158.8M | -441.4% |
| Interest Expense | $9.6M | +270.0% |
| Pre-tax Income | -$217.4M | -260.7% |
| Income Tax | $357K | — |
| Net Income | -$217.8M | -296.7% |
| EPS (Basic) | -$5.00 | -201.2% |
| EPS (Diluted) | -$5.00 | -201.2% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $67.3M | +366.8% |
| Accounts Receivable | $1.4M | +105.8% |
| Current Assets | $131.9M | +523.1% |
| Total Assets | $142.0M | +337.9% |
| Current Liabilities | $36.8M | +11.5% |
| Total Liabilities | $94.3M | +27.1% |
| Stockholders' Equity | $47.7M | +214.2% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$106.6M | -395.7% |
| Capital Expenditures | $562K | +921.8% |
| Investing Cash Flow | -$3.3M | -75.8% |
| Financing Cash Flow | $159.4M | +347.0% |
| Free Cash Flow | -$107.1M | -397.0% |